31st Mar 2008 07:01
Sinclair Pharma PLC31 March 2008 Sinclair Pharma plc (the "Company") The Company was informed on 28 March that Michael Flynn, Chief-ExecutiveOfficer, acquired 4,000 ordinary shares of 1p each ("Ordinary Shares") at anaverage price of 35.7p. Following this acquisition of Ordinary Shares, Dr. Flynn will be interested in9,508,000 Ordinary Shares equalling approximately 10.2% per cent of the issuedshare capital in the Company. The Company was also informed on 28 March 2008 that Jerry Randall, ChiefFinancial Officer, acquired 30,000 Ordinary Shares at 35.0 pence per share on 28March 2008. Following this acquisition of Ordinary Shares Mr. Randall has an interest in atotal of 535,000 Ordinary Shares equalling approximately 0.57 per cent. of theissued share capital in the Company. For further information please contact: Sinclair Pharma plc Tel: +44 (0) 1483 410 600 Dr Michael Flynn, CEO This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Sinclair Pharma